These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 9475265)

  • 1. Cardiovascular effect of a new 1,5-benzothiazepine derivative TA-993 in anesthetized dogs.
    Kaburaki M; Narita H; Yabana H; Karasawa T; Doi H; Murata S
    J Cardiovasc Pharmacol; 1998 Feb; 31(2):240-7. PubMed ID: 9475265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular effects of 1,5-benzothiazepine derivatives having a l-cis and d-cis configuration in anesthetized dogs.
    Kaburaki M; Inoue H; Doi H; Yasuhara M; Narita H
    Biol Pharm Bull; 1998 Jan; 21(1):50-5. PubMed ID: 9477168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular effects of a new 1,5-benzothiazepine calcium antagonist in anesthetized dogs.
    Murata S; Kikkawa K; Yabana H; Nagao T
    Arzneimittelforschung; 1988 Apr; 38(4):521-5. PubMed ID: 3401267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antithrombotic action of TA-993, a new 1,5-benzothiazepine derivative, in a canine model of femoral arterial thrombosis.
    Kaburaki M; Doi H; Narita H; Odawara A; Yasoshima A; Murata S
    J Cardiovasc Pharmacol; 1998 Mar; 31(3):470-7. PubMed ID: 9514194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The mechanism of the increasing action of TA-993, a new 1,5- benzothiazepine derivative, on limb blood flow in anesthetized dogs: selective suppression of sympathetic nerve activity.
    Kaburaki M; Yabana H; Doi H; Nagata K; Narita H; Murata S
    J Pharmacol Exp Ther; 1999 Mar; 288(3):1167-73. PubMed ID: 10027855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascular actions of TA 3090, a novel analog of diltiazem: interaction with endothelium-dependent relaxation in canine femoral and coronary arteries.
    Rubanyi G; Iqbal A; Schwartz A; Vanhoutte PM
    J Pharmacol Exp Ther; 1991 Nov; 259(2):639-42. PubMed ID: 1941612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peripheral vasodilator and cardiac properties of the 1,5-benzothiazepine calcium antagonist analog, TA-3090, in dogs.
    Dumont L; Derouin M; Chartrand C; Archambeault P; Garceau D; Caillé G
    Can J Physiol Pharmacol; 1991 Apr; 69(4):512-7. PubMed ID: 2059913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of diltiazem hydrochloride (CRD-401) on hepatic, superior mesenteric and femoral hemodynamics.
    Ishikawa H; Matsushima A; Matsui H; Shindo T; Morifuji T; Okabayashi M
    Arzneimittelforschung; 1978; 28(3):400-2. PubMed ID: 580747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitory effects of TA-993, a new 1,5-benzothiazepine derivative, on platelet aggregation.
    Odawara A; Kikkawa K; Katoh M; Toryu H; Shimazaki T; Sasaki Y
    Circ Res; 1996 Apr; 78(4):643-9. PubMed ID: 8635222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of KT-362, a new calcium release blocker, on vascular selectivity and hemodynamic actions in anesthetized dogs.
    Wakabayashi S; Mochizuki S; Tomiyama A; Shibata S
    Jpn J Pharmacol; 1990 Sep; 54(1):23-32. PubMed ID: 2273645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcium antagonistic and spasmolytic activities of a new 1,5-benzothiazepine derivative in isolated canine and monkey arteries.
    Kikkawa K; Murata S; Nagao T
    Arzneimittelforschung; 1988 Apr; 38(4):526-31. PubMed ID: 3165267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological studies on a new antihypertensive agent, S-2150, a benzothiazepine derivative: 3. Hypotensive and antimyocardial-stunning effects in dogs.
    Kimoto S; Haruna M; Matsuura E; Uno O; Ishii M; Hirono S; Yoshimura K; Ueda M; Iwaki K
    J Cardiovasc Pharmacol; 1997 Feb; 29(2):180-7. PubMed ID: 9057066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of diltiazem on hemodynamics and His bundle electrogram in the anesthetized dog (author's transl)].
    Nagao T; Murata S; Ikezawa K; Ikeo T; Narita H; Sato M
    Nihon Yakurigaku Zasshi; 1981 Feb; 77(2):195-203. PubMed ID: 7239361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebral vasodilating and spasmolytic actions of a new Ca-antagonist, clentiazem (TA-3090), in anesthetized animals.
    Murata S; Kikkawa K; Nagao T
    J Cardiovasc Pharmacol; 1992 May; 19(5):790-7. PubMed ID: 1381778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms of action of OPC-28326, a selective hindlimb vasodilator.
    Orito K; Imaizumi T; Yoshida K; Fujiki H; Kishi M; Teramoto S; Tanaka M; Shimizu H; Tominaga M; Kimura Y; Kambayashi J; Mori T
    J Pharmacol Exp Ther; 1999 Nov; 291(2):604-11. PubMed ID: 10525078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular effects of YM099, a novel K+ channel opener, in anesthetized and conscious dogs.
    Uchida W; Hirano Y; Taguchi T; Masuda N; Shirai Y; Satoh N; Takenaka T
    Eur J Pharmacol; 1994 Nov; 264(3):285-93. PubMed ID: 7698167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel orally active dopamine prodrug TA-870. III. Positive inotropic effect and cardiorenal selectivity in anesthetized dogs.
    Nishiyama S; Yamaguchi I; Akimoto Y; Yoshikawa M; Nakajima H
    J Cardiovasc Pharmacol; 1990 Feb; 15(2):283-90. PubMed ID: 1689425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of piperidine and its related substances on blood vessels.
    Aisaka K; Hattori Y; Ishihara T; Morita M; Kasé Y; Miyata T
    Jpn J Pharmacol; 1985 Apr; 37(4):345-53. PubMed ID: 4010086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of a cardiotonic agent, TA-064, on isolated canine cerebral, coronary, femoral, mesenteric, and renal arteries.
    Ozaki N; Bito K; Kinoshita M; Kawakita S
    J Cardiovasc Pharmacol; 1983; 5(5):818-21. PubMed ID: 6195470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-lasting hypotensive and antihypertensive effects of a new 1,5-benzothiazepine calcium antagonist in hypertensive rats and renal hypertensive dogs.
    Narita H; Murata S; Yabana H; Kikkawa K; Sugawara Y; Akimoto Y; Nagao T
    Arzneimittelforschung; 1988 Apr; 38(4):515-20. PubMed ID: 3041970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.